CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Aug 10, 2022. (Total: 3965 publications since 2011)

All HLBS RCH FHH Equity Diabetes Rare Cancer COVID-19 ND PGx PI Environmental dataset

Filtered By: Select to fine-tune your search CDC Author Year CDC Organization Journal

Records 1-11 (of 11 Records)

Query Trace: all>>Claire Y-H Huang[CDC Author]
Genetic Adaptation by Dengue Virus Serotype 2 to Enhance Infection of Aedes aegypti Mosquito Midguts. Steven M Erb, Siritorn Butrapet, John T Roehrig, Claire Y-H Huang, and Carol D Blair Viruses 2022 14(7) Similar articles in PubMed DOI:10.3390/v14071569
Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virus. Whitney R Baldwin, Holli A Giebler, Janae L Stovall, Ginger Young, Kelly J Bohning, Hansi J Dean, Jill A Livengood, and Claire Y-H Huang Nature communications 2021 12(1) 7320 Similar articles in PubMed DOI:10.1038/s41467-021-27578-w
Mutations in the West Nile prM protein affect VLP and virion secretion in vitro. Amanda E Calvert, Claire Y-H Huang, Carol D Blair, and John T Roehrig Virology 2012 Nov 433(1) 35-44 Similar articles in PubMed DOI:10.1016/j.virol.2012.07.011
Japanese encephalitis vaccine-specific envelope protein E138K mutation does not attenuate virulence of West Nile virus. Jaclyn A Kaiser, Huanle Luo, Steven G Widen, Thomas G Wood, Claire Y-H Huang, Tian Wang, and Alan D T Barrett NPJ vaccines 2019 50 Similar articles in PubMed DOI:10.1038/s41541-019-0146-0
Genotypic and phenotypic characterization of West Nile virus NS5 methyltransferase mutants. Jaclyn A Kaiser, Huanle Luo, Steven G Widen, Thomas G Wood, Claire Y-H Huang, Tian Wang, and Alan D T Barrett Vaccine 2019 Oct Similar articles in PubMed DOI:10.1016/j.vaccine.2019.09.045
West Nile Virus Temperature Sensitivity and Avian Virulence Are Modulated by NS1-2B Polymorphisms. Elizabeth A Dietrich, Stanley A Langevin, Claire Y-H Huang, Payal D Maharaj, Mark J Delorey, Richard A Bowen, Richard M Kinney, and Aaron C Brault PLoS neglected tropical diseases 2016 Aug (8) e0004938 Similar articles in PubMed DOI:10.1371/journal.pntd.0004938
Molecular determinants of dengue virus 2 envelope protein important for virus entry in Fc?RIIA-mediated antibody-dependent enhancement of infection. Nunya Chotiwan, John T Roehrig, Jacob J Schlesinger, Carol D Blair, and Claire Y-H Huang Virology 2014 May 456-457238-46 Similar articles in PubMed DOI:10.1016/j.virol.2014.03.031
A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates. Yuping Ambuel, Ginger Young, Joseph N Brewoo, Joanna Paykel, Kim L Weisgrau, Eva G Rakasz, Aurelia A Haller, Michael Royals, Claire Y-H Huang, Saverio Capuano, Dan T Stinchcomb, Charalambos D Partidos, and Jorge E Osorio Front Immunol 2014 5263 Similar articles in PubMed DOI:10.3389/fimmu.2014.00263
Mutation of the dengue virus type 2 envelope protein heparan sulfate binding sites or the domain III lateral ridge blocks replication in Vero cells prior to membrane fusion. John T Roehrig, Siritorn Butrapet, Nathan M Liss, Susan L Bennett, Betty E Luy, Thomas Childers, Karen L Boroughs, Janae L Stovall, Amanda E Calvert, Carol D Blair, and Claire Y-H Huang Virology 2013 Jul 5. 441(2) 114-25 Similar articles in PubMed DOI:10.1016/j.virol.2013.03.011
Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax). Claire Y-H Huang, Richard M Kinney, Jill A Livengood, Bethany Bolling, John J Arguello, Betty E Luy, Shawn J Silengo, Karen L Boroughs, Janae L Stovall, Akundi P Kalanidhi, Aaron C Brault, Jorge E Osorio, and Dan T Stinchcomb PLoS Negl Trop Dis 2013 7(5) e2243 Similar articles in PubMed DOI:10.1371/journal.pntd.0002243
Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever. Jorge E Osorio, Claire Y-H Huang, Richard M Kinney, and Dan T Stinchcomb Vaccine 2011 Sep 23. 29(42) 7251-60 Similar articles in PubMed DOI:10.1016/j.vaccine.2011.07.020